Related Experiment Video
Updated: Apr 6, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Popliteal sentinel lymph node involvement in melanoma patients
Eduardo Bertolli1, José Luiz Barbosa Bevilacqua2, André Sapata Molina1
1Skin Cancer Department, AC Camargo Cancer Center, São Paulo/SP, Brazil.
Sentinel lymph node (SLN) biopsies in the popliteal basin, though rare, are linked to worse disease-free survival in melanoma patients. This finding suggests popliteal drainage indicates poorer prognostic features of the primary tumor.
Area of Science:
- Oncology
- Surgical Pathology
- Dermatology
Background:
- Sentinel lymph nodes (SLN) in popliteal basins are uncommon, with debated origins, management, and outcomes.
- Popliteal SLN drainage presents unique challenges in melanoma staging and prognosis.
Purpose of the Study:
- To correlate clinical and pathological features of popliteal basin lymphatic drainage.
- To analyze the impact of popliteal lymph node drainage on patient survival outcomes.
Main Methods:
- Retrospective analysis of SLN biopsies conducted at a single institution from 2000 to 2010.
- Evaluation of 247 SLN biopsies in patients with lower limb melanoma.
Main Results:
- Twenty-seven patients (11%) exhibited popliteal drainage, with three (11%) having popliteal metastasis.
- Popliteal drainage was associated with significantly worse 5-year disease-free survival (DFS) (P=0.028).
- Multivariate analysis identified Breslow thickness, mitotic index, and positive SLN as prognostic factors for DFS.
Conclusions:
- Popliteal lymphatic drainage in melanoma patients appears to correlate with adverse prognostic indicators.
- The presence of popliteal SLN metastasis may signify a more aggressive tumor profile.
More Related Videos
07:51The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021